The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Background Hepatic metastases develop in approximately 50% of colorectal cancer (CRC)
cases. We performed a review and meta-analysis to evaluate survival after resection of CRC …

Liver metastases develop in more than half of the patients with colorectal cancer (CRC) and
are associated with a poor prognosis. The factors influencing liver metastasis of CRC are …

Chimeric antigen receptor-modified T cell (CAR-T) technology, a promising
immunotherapeutic tool, has not been applied specifically to treat liver metastases (LM) …

US9255907B2 - Identification of surgical smoke - Google Patents US9255907B2 -
Identification of surgical smoke - Google Patents Identification of surgical smoke Download …

Despite tremendous medical treatment successes, colorectal cancer (CRC) remains a
leading cause of cancer deaths worldwide. Chemotherapy as monotherapy can lead to …

Purpose To evaluate the performance, agreement, and efficiency of a fully convolutional
network (FCN) for liver lesion detection and segmentation at CT examinations in patients …

Abstract Intercellular adhesion molecule (ICAM)-1, is a transmembrane glycoprotein of the
immunoglobulin (Ig)-like superfamily, consisting of five extracellular Ig‑like domains, a …

Despite recent advances in oncologic therapy, an important proportion of patients with
primary cancer will develop distant metastasis. The standard therapy for metastatic cancer is …

90Y radioembolization (selective internal radiation therapy [SIRT]) is a valuable therapeutic
option for unresectable hepatic metastases arising from primary colorectal cancer. The …